Evaluating LEAPs Performance

LEAPs offer long-dated leverage on companies you already believe are undervalued. The promise is clear: control more shares with less cash while aligning with a long-term thesis. The risk is subtle: theta, IV shifts, and poor strike choices can quietly erase that edge. Testing LEAPs means measuring whether the leverage truly improves risk-adjusted returns versus owning the stock.

TL;DR

• Anchor LEAP strikes to intrinsic value and required margin of safety before testing outcomes.
• Track delta, break-even, and theta decay over time to see if leverage is paying for itself.
• Compare LEAP performance to buying shares plus covered calls to judge opportunity cost.
• Monitor roll frequency and cost so leverage does not become an endless fee.
• Use risk-adjusted metrics, not just raw gains, to decide if LEAPs belong in your playbook.

Purpose and reader question

Purpose: Apply.
Central question: Do LEAPs meaningfully improve returns for a long-term value thesis after accounting for decay, volatility changes, and roll costs?

Key concepts: delta path, theta drag, roll cost, risk-adjusted return.
Why it matters: Leverage tempts investors to overlook decay and fees. Testing forces you to prove that the leveraged exposure beats simply owning shares with discipline.

Choose the right test setup

• Strike relative to value: Start with deep ITM or at-the-money strikes near your Wall St Yardie fair-value estimate. Avoid OTM lottery tickets.
• Tenor: 12–24 months is the sweet spot for balancing time value and theta. Test multiple tenors to see decay differences.
• Position size: Cap LEAP premium to a fixed percentage of portfolio so leverage cannot overwhelm drawdowns.

Measure delta path and participation

Track delta at entry and quarterly thereafter. Healthy LEAPs maintain high delta, meaning they participate in the stock’s upside similar to shares. If delta collapses because the contract drifts OTM, your leverage has turned into speculation. Record how often delta stays above 0.70; below that, consider rolling or exiting.

Break-even and margin of safety

Calculate break-even: strike + premium paid. Compare it to fair value. If break-even sits above intrinsic value, the LEAP requires multiple bullish surprises just to break even, violating margin of safety. Favor setups where break-even remains below or near your buy-price band.

Numeric example

Fair value from the Wall St Yardie app: $90 with a buy zone at $75. You purchase a 18-month $70 call for $12 when the stock trades at $78.

• Delta: ~0.75 at entry.
• Break-even: $70 + $12 = $82, which is inside the value range.
• Capital outlay: $1,200 controls 100 shares versus $7,800 to own them.
• If the stock reaches fair value ($90) within a year, intrinsic value in the LEAP = $20, turning $1,200 into roughly $2,000 before theta and bid-ask. That leverage is meaningful because break-even sat below fair value.

Track theta and IV impact

Log theta at entry and quarterly. Rising theta as expiration approaches is expected, but if premium erosion outpaces stock appreciation, leverage is failing. Pair this with implied volatility changes: falling IV can cut LEAP value even when price rises. Backtests should include scenarios with shrinking IV to see how sensitive profits are to vol compression.

Rolling costs and timing

Many investors roll LEAPs to maintain exposure. Record how often you roll, the debit or credit paid, and the new break-even. If cumulative roll costs push break-even above intrinsic value, the strategy erodes your margin of safety. Consider blending LEAPs with covered calls (poor man’s covered call) and track if those calls offset roll costs without suffocating upside.

Compare to stock alternatives

Test LEAP performance against two benchmarks: owning shares outright, and owning shares while selling periodic covered calls. This exposes whether leverage is actually delivering better risk-adjusted returns or simply adding complexity. Use /blog/boosting-returns-with-leaps-leverage/leaps-leverage-math to sanity-check your leverage expectations.

Evaluate downside behavior

Measure max drawdown of LEAP value versus drawdown of the underlying shares from your ECb. A LEAP can lose 60% while the stock slips 15% because of time value loss. Decide if that volatility fits your psychology; if not, size smaller or pair with protective puts and test the combo separately.

What could go wrong?

• Choosing OTM strikes: Cheap premiums with low delta often expire worthless. Stick to ITM or close-to-money strikes aligned with valuation.
• Ignoring vol crush: Buying after news or during high IV sets you up for quick premium decay. Wait for calmer IV percentiles unless the valuation edge is huge.
• Over-rolling: Frequent rolls eat the leverage benefit. Set rules for when to hold versus roll, and cap roll costs as a percentage of original premium.
• Forgetting fundamentals: A weakening moat makes leverage dangerous. Revisit /blog/fundamentals-of-value-investing/fundamentals-wonderful-companies before renewing any LEAP.

Next steps checklist

• Set strike and tenor rules tied to Wall St Yardie fair-value ranges and delta targets.
• Backtest LEAPs versus stock-only and stock-plus-covered-call benchmarks across multiple volatility regimes.
• Track delta path, theta drag, and roll costs for at least 15 sample trades; retire setups that push break-even above fair value.
• Define a max drawdown threshold for LEAP value and reduce size if breached.
• Journal findings and update your playbook alongside /blog/testing-and-refining-your-value-options-strategy/testing-backtesting and /blog/boosting-returns-with-leaps-leverage/leaps-leverage-exit-strategies.